TITLE:
Sitosterolemia Extension Study (0653-004)(COMPLETED)

CONDITION:
Lipid Metabolism, Inborn Errors

INTERVENTION:
MK0653, ezetimibe

SUMMARY:

      This is an extension study for patients having unusually high absorption of non-cholesterol
      sterols, resulting in heart-related diseases. This study will evaluate the long term safety
      and the ability to lower cholesterol levels with an investigational drug.
    

DETAILED DESCRIPTION:

      The duration of treatment is 52 weeks.
    

ELIGIBILITY:
Gender: All
Age: 10 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patients with elevated sitosterol levels while taking current medication

        Exclusion Criteria:

          -  Patient has a condition which, in the opinion of the investigator, might pose a risk
             to the patient, interfere with participation in the study, or does not meet the
             additional criteria as required by the study.
      
